A detailed history of Advisor Group Holdings, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 9,188 shares of INCY stock, worth $687,262. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,188
Previous 11,131 17.46%
Holding current value
$687,262
Previous $674,000 9.94%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$57.33 - $68.61 $111,392 - $133,309
-1,943 Reduced 17.46%
9,188 $607,000
Q2 2024

Aug 13, 2024

BUY
$51.18 - $63.75 $61,057 - $76,053
1,193 Added 12.0%
11,131 $674,000
Q1 2024

May 10, 2024

SELL
$56.55 - $66.59 $491,306 - $578,533
-8,688 Reduced 46.64%
9,938 $566,000
Q4 2023

Feb 12, 2024

SELL
$52.16 - $64.19 $1.21 Million - $1.48 Million
-23,121 Reduced 55.38%
18,626 $1.17 Million
Q3 2023

Nov 13, 2023

BUY
$57.77 - $65.93 $495,955 - $566,009
8,585 Added 25.89%
41,747 $2.41 Million
Q2 2023

Aug 21, 2023

SELL
$60.95 - $75.51 $22,429 - $27,787
-368 Reduced 1.1%
33,162 $2.06 Million
Q2 2023

Aug 10, 2023

BUY
$60.95 - $75.51 $820,508 - $1.02 Million
13,462 Added 67.08%
33,530 $2.09 Million
Q1 2023

May 12, 2023

SELL
$70.23 - $86.01 $216,308 - $264,910
-3,080 Reduced 13.31%
20,068 $1.45 Million
Q4 2022

Feb 10, 2023

BUY
$67.18 - $84.11 $741,398 - $928,237
11,036 Added 91.12%
23,148 $1.86 Million
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $310,450 - $388,696
4,691 Added 63.21%
12,112 $806,000
Q2 2022

Aug 10, 2022

BUY
$66.18 - $83.18 $28,060 - $35,268
424 Added 6.06%
7,421 $564,000
Q1 2022

May 04, 2022

BUY
$66.02 - $79.71 $51,297 - $61,934
777 Added 12.49%
6,997 $590,000
Q3 2021

Nov 05, 2021

SELL
$68.67 - $84.02 $68,532 - $83,851
-998 Reduced 13.83%
6,220 $429,000
Q2 2021

Aug 02, 2021

SELL
$79.87 - $87.53 $43,449 - $47,616
-544 Reduced 7.01%
7,218 $606,000
Q1 2021

May 13, 2021

SELL
$76.02 - $100.5 $141,245 - $186,729
-1,858 Reduced 19.31%
7,762 $633,000
Q4 2020

Feb 10, 2021

SELL
$80.74 - $97.7 $24,222 - $29,310
-300 Reduced 3.02%
9,620 $837,000
Q3 2020

Nov 12, 2020

BUY
$85.07 - $109.69 $35,729 - $46,069
420 Added 4.42%
9,920 $893,000
Q2 2020

Aug 14, 2020

SELL
$74.18 - $108.93 $13,055 - $19,171
-176 Reduced 1.82%
9,500 $988,000
Q1 2020

May 18, 2020

BUY
$63.18 - $85.97 $611,329 - $831,845
9,676 New
9,676 $710,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.